A Phase II, randomized, observer-blind, controlled, age de-escalation study in approximately 140 toddlers and 700 infants in the US and Canada. This study is to asses the Safety and Immunogenicity of a Pheumococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers Infants.

Register Today!.

Trial Information

Start DateFall 2020
End DateTBD
Trial DurationApproximately 15 months
Number of Visits6 visits and 5 phone calls
Lead CRCAdam Pawluch
StatusUpcoming Trial

For additional information
on this trial contact: